NFO period: 09^th June - 23^rd June, 2025

Highlights of the NFO:

• Scheme type - An open ended equity scheme investing in Pharma and Healthcare sector.


• Investment objective - The primary objective of the Scheme is to provide long-term capital appreciation by investing predominantly in equity and equity related instruments of Pharma and Healthcare companies. The Scheme does not guarantee/indicate any returns. However, there can be no assurance that the investment objective of the Scheme will be realized.


• Product suitability - This product is suitable for investors who are seeking to generate long term wealth creation. Investment predominantly in equity & equity related instruments of Pharma and Healthcare Companies.


• Minimum Application Amount - Rs. 1000/- and in multiples of Re. 1/- thereafter.


• Plan/ Options available - Regular plan & Direct plan having Growth Option and Income Distribution cum Capital Withdrawal (IDCW) Option (with Payout of Income Distribution cum capital withdrawal option and Reinvestment of Income Distribution cum capital withdrawal option).


• Fund Managers - Mr. Sanjay Chawla


• Benchmark - BSE Healthcare Total Return Index